"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Descriptor ID |
D003930
|
| MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
| Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 3 | 1 | 4 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 1 | 4 |
| 2019 | 5 | 0 | 5 |
| 2020 | 1 | 1 | 2 |
| 2021 | 8 | 0 | 8 |
| 2022 | 3 | 0 | 3 |
| 2023 | 6 | 0 | 6 |
| 2024 | 6 | 0 | 6 |
| 2025 | 3 | 0 | 3 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Case series: The role of retinal ischemia in the pathogenesis and clinical manifestation of diabetic retinopathy. Optom Vis Sci. 2026 Aug; 103(8):e70090.
-
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. Ophthalmology. 2026 Jul; 133(7):837-851.
-
Short-term effects of tetracycline use in patients with diabetic retinopathy. Can J Ophthalmol. 2025 12; 60(6):e858-e868.
-
Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study. BMC Ophthalmol. 2025 Jan 17; 25(1):24.
-
Glucose-Sensing Carbohydrate Response Element-Binding Protein in the Pathogenesis of Diabetic Retinopathy. Cells. 2025 01 13; 14(2).
-
Follow-up Adherence After Teleretinal Screening for Diabetic Retinopathy. Int Ophthalmol Clin. 2025 Jan 01; 65(1):35-39.
-
Glucagon-like Peptide-1 Receptor Agonists in the Management of Diabetic Retinopathy. Int Ophthalmol Clin. 2025 01 01; 65(1):23-26.
-
Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease. Int Ophthalmol Clin. 2025 Jan 01; 65(1):27-33.
-
Optimal Humanized Scg3-Neutralizing Antibodies for Anti-Angiogenic Therapy of Diabetic Retinopathy. Int J Mol Sci. 2024 Sep 01; 25(17).
-
Effectiveness of Conventional Digital Fundus Photography-Based Teleretinal Screening for Diabetic Retinopathy and Diabetic Macular Edema: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024 08; 131(8):927-942.